Principal – New Ventures
Osanni Bio
Principal – New Ventures
Osanni Bio
Development-stage therapeutics platform advancing drug programs
Who We Are:
Osanni is a development-stage therapeutics platform, headquartered in San Francisco, California. We are creative and agile innovators, relentlessly curious about finding new ways to target the biology behind diseases with the greatest unmet need and determined to do something about it.
At the center of Osanni is its innovation engine, which is optimized for discovering new scientific insights, designing novel drug concepts, and efficiently advancing programs to a meaningful proof-of-concept. Once a program is sufficiently de-risked, it graduates into its ecosystem of affiliate companies (Avians), which are equipped with the dedicated focus, specialized talent and support necessary to scale. Osanni's architecture marries the scientific depth and operational power of a centralized platform with the speed, agility and accountability of independent companies. The result: an opportunity to create and deliver more transformative medicines.
We hold patients and the physicians who care for them as our North Star. It guides our purpose, sharpens our decision-making, and defines our impact. Osanni is currently advancing programs in ophthalmology, cardiology and beyond. We are building a highly skilled team, passionate about having an impact on human health. Be part of creating an organization where people enjoy their work and their colleagues, are valued for their individuality, and can't imagine working anywhere else.
This role is based in the San Francisco Bay Area and requires working on-site 3 days/week.
About the Role:
Osanni is seeking an entrepreneurial Principal, New Ventures to drive opportunity screening and lead the development of novel program concepts from early scientific insight through a clear path toward proof-of-concept.
You'll partner closely with the Sr. Director, Discovery Innovation and the broader Discovery Innovation team to discover and evaluate therapeutic opportunities, build the case for which ones are worth pursuing, and move fast past the ones that aren’t. You'll engage external partners, advisors, and key opinion leaders to stress-test and strengthen that thinking. A central part of the role is defining the full opportunity story for a given program, not just the science, but the target product profile, competitive landscape, regulatory pathway, and commercial and IP strategy, and using that story to guide what advances and what doesn't.
This is a high-ownership, high-velocity role. The Discovery Innovation team is small and still building its process, so you'll be defining how this work gets done as much as doing it. Your calls on what advances carry real weight: what you build the case for becomes the programs Osanni is known for internally and externally, which makes this a high-visibility seat with real responsibility attached. Decisions move fast here, and so should you. This role is based out of our San Francisco Bay Area headquarters (hybrid, on-site required) and reports directly to the Sr. Director, Discovery Innovation.
What You Will Do:
What You Bring:
#LI-hybrid
Below is the expected base pay range for this position plus bonus and comprehensive benefits. The base pay range reflects the target range for this position, but individual pay will be determined by additional factors such as job-related skills, experience and relevant education or training.
We are committed to creating a diverse environment and are proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
We will provide an intellectually stimulating, collegial and fast-paced environment. If you are ready to be a part of building the future of transformative medicines, then we are excited to hear from you!
Base Pay 190000 - 215000 USD
Development-stage therapeutics platform advancing drug programs
Osanni Bio uses a centralized innovation engine paired with a network of affiliate companies to discover, de-risk, and advance drug programs to proof-of-concept, then spins out successful programs as independent companies to scale. It generates drug concepts and progresses them to PoC through its central research engine and affiliate network. Unlike traditional pharma pipelines, it combines central science with a spin-out model to pursue capital-efficient, rapid PoC development. Its goal is to accelerate medicines in ophthalmology and cardiology with efficient progression to PoC and scalable programs.
Explore more opportunities at Osanni Bio